Резултати
eNauka >
Results >
Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study
| Title: | Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study | Authors  : | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana; ...; Stamatovic, Ljiljana | Issue Date: | 2020 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 31 str. S306-S307 | DOI: | 10.1016/j.annonc.2020.08.287 | WoS-ID: | 000573469100165 | URI: | https://enauka.gov.rs/handle/123456789/796971 | Project: | F. Hoffmann-La Roche Ltd.Hoffmann-La Roche | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.